Anesth Analg 2005;101:1054-1059
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ane.0000166955.97368.80
ANESTHETIC PHARMACOLOGY
Inhibitory Effects of Intravenous Anesthetics on Mast Cell Function
Takahiro Fujimoto, MD, PhD,
Tomoki Nishiyama, MD, PhD, and
Kazuo Hanaoka, MD, PhD
Department of Anesthesiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Address correspondence and reprint requests to Takahiro Fujimoto, MD, PhD, zip151-0072 3-33-1-502 Hatayaga, Shibuya ward, Tokyo, Japan. Address e-mail to tfujimot{at}highway.ne.jp.
Mast cells play a protective role in the inflammation and auto-tissue injury. The impairment of mast cell function may influence defense against infection. We investigated the effect of four IV anesthetics (thiopental, midazolam, ketamine, and propofol) on the chemotaxis and exocytosis of mast cells. Canine mast cell chemotaxis was measured by the Boyden's blindwell chamber technique using 100 µg/mL of substance P as a stimulator. We measured mast cell exocytosis by measuring released histamine from mast cells using substance P or gamma-monomeric IgG-mediated crosslinking as a stimulator. Thiopental, midazolam, and propofol exerted a dose-dependent inhibitory effect on mast cell chemotaxis. Ketamine, midazolam, and propofol had a dose-dependent inhibitory effect on mast cell exocytosis. In conclusion, midazolam and propofol inhibited both chemotaxis and exocytosis of mast cells, while thiopental only inhibited chemotaxis, and ketamine only inhibited exocytosis.
This article has been cited by other articles:

|
 |

|
 |
 
N. Ohta, Y. Ohashi, and Y. Fujino
Ketamine Inhibits Maturation of Bone Marrow-Derived Dendritic Cells and Priming of the Th1-Type Immune Response
Anesth. Analg.,
September 1, 2009;
109(3):
793 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|